8YHV

Structure of the VP40 from Biortus.

PDB DOI: https://doi.org/10.2210/pdb8YHV/pdb

Classification: VIRAL PROTEIN
Organism(s): Ebola virus - Zaire (1995)
Expression System: Escherichia coli
Mutation(s): No

Deposited: 2024-02-28 Released: 2024-03-13
Deposition Author(s): Wang, F., Cheng, W., Lv, Z., Meng, Q., Zhang, B.
Funding Organization(s): Not funded

Experimental Data Snapshot

Method: X-RAY DIFFRACTION
Resolution: 2.35 Å
R-Value Free: 0.223
R-Value Work: 0.174

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

This is version 1.0 of the entry. See complete history.

Literature

Structure of the VP40 from Biortus.

Wang, F., Cheng, W., Lv, Z., Meng, Q., Zhang, B.

To be published.

Macromolecule Content

Total Structure Weight: 31.86 kDa
Atom Count: 1,991
Modelled Residue Count: 245
Deposited Residue Count: 296
Unique protein chains: 1

Macromolecules

Find similar proteins by:

(by identity cutoff) | 3D Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Matrix protein VP40	A	296	Ebola virus - Zaire (1995)	Mutation(s): 0 Gene Names: VP40
UniProt
Find proteins for Q77DJ6 (Zaire ebolavirus (strain Kikwit-95)) Explore Q77DJ6 Go to UniProtKB: Q77DJ6
Entity Groups
Sequence Clusters	30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt Group	Q77DJ6
Sequence Annotations Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

Method: X-RAY DIFFRACTION
Resolution: 2.35 Å
R-Value Free: 0.223
R-Value Work: 0.174
Space Group: C 1 2 1

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 65.031	α = 90
b = 90.812	β = 97.816
c = 49.22	γ = 90

Software Package:

Software Name	Purpose
REFMAC	refinement
XDS	data reduction
Aimless	data scaling
PHASER	phasing

Structure Validation

View Full Validation Report

Entry History & Funding Information

Deposition Data

Released Date: 2024-03-13

Deposition Author(s):

Funding Organization	Location	Grant Number
Not funded		--

Revision History (Full details and data files)

Version 1.0: 2024-03-13
Type: Initial release

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.